My opinion is your opinion is bought… the FDA will approve DCVax if they just approved a MAB with a CR of 42% and an AE profile of: “Serious toxicities occurred in 62% of patients, and 8% of patients experienced adverse reactions that proved to be fatal. Fatal toxicities included multiorgan failure, lung infection, sepsis, and encephalopathy. Moreover, 11% of patients required dose interruptions due to an adverse effect (AE) and 21% experienced an AE that led to permanent treatment discontinuation.”